Month: May 2017

Stampeding Generics Expected to Trample Lily’s now off-patent ADHD med Strattera

http://www.fiercepharma.com/pharma/lilly-s-adhd-med-strattera-faces-new-generic-competition-from-teva-and-others?utm_medium=nl&utm_source=internal&mrkid=41785545&mkt_tok=eyJpIjoiWWpGaE1qQTBZMkptTVRReCIsInQiOiJvMElvYVNsOHNHSHlTVFMyNzhtMkI1WEVBSW5xTk0xU08xUnZmYlVmMVk2YkI5bTkzeXlmM3RLOGZpa3NRWVFPcmlPWUhPQ1JpM3VTS2liblF5ZDRQb0NDQUpGdUhEbGcwcVpmaGR6YmtlVEdpRkVrcjEydmg2ODhwaUZsZXROaSJ9

Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles: Recall of Lot # JB5047 – Due to Report of Another Medicine in One Bottle

AstraZeneca is notifying physicians and consumers that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of Brilinta (ticagrelor) 90mg tablets as a precautionary measure. This voluntary recall follows a report that a professional sample

Proposed Cuts to Pharmacy Reimbursement

You’re already fighting the proposed cuts to PACE and Medicaid dispensing fees, but your patients need to understand the detrimental effect these proposals would have on them. Discuss these proposals with your patients to help them understand the harmful consequences

PARD Dinner Dance held April 29, 2017 at the Philadelphia Zoo

Drug Lobbyists’ Battle Cry Over Prices: Blame the Others

A civil war has broken out among the most powerful players in the industry, which is scrambling in the face of public anger and legislative efforts to reduce costs. https://www.nytimes.com/2017/05/29/health/drug-lobbyists-battle-cry-over-prices-blame-the-others.html?smprod=nytcore-ipad&smid=nytcore-ipad-share

New FDA Commissioner Gottlieb Unveils Price-fighting Strategies

http://www.fiercepharma.com/pharma/new-fda-commissioner-gottlieb-unveils-price-fighting-strategies?utm_medium=nl&utm_source=internal&mrkid=41785545&mkt_tok=eyJpIjoiTlRKalpUSmxOREEwTW1NNSIsInQiOiJrNW9ncDJJQjZhSUQrSDdFcHA3YWcyd1MwQXQwODA3dmQydDZcL2k5a0hPbkp5cFlFYVhqMzdOWHlWRDQ3Q2R1TGpEXC90NExwQVpQUHBOa3VmdU1Vc3hva0wwaU1UT2F0NlRlNDZQRFpmY25xXC8weHFIcDF6cVZubXdFUGRJdXJWMCJ9

FDA Commissioner Asks Staff for ‘More Forceful Steps’ to Stem Opioid Crisis

https://blogs.fda.gov/fdavoice/index.php/2017/05/fda-commissioner-asks-staff-for-more-forceful-steps-to-stem-the-opioid-crisis/

Invite Your Legislator for a Pharmacy Visit Over the Memorial Day Recess

Congress will be in recess from May 26-June 5 for the Memorial Day holiday. Many legislators will be in their districts meeting with constituents and attending local events. This is an opportune time to engage your legislators and invite them

A Reality Check on Amazon’s Pharmacy Ambitions

Click on the link below to see the article. A Reality Check on Amazon’s Pharmacy Ambitions 

NCPA Advocacy Center Update – Week Ending May 20, 2017

CMS Releases Annual Part D Plan Sponsor DIR Reporting Guidance Including Details on Reporting Pharmacy DIR:  This week CMS released a memo proposing guidance for Part D sponsors on reporting DIR data for CY 2016.  Part D sponsors are required

Mel Brodsky, Executive Director of PARD, Presents a Check to the Police Athletic League of Philadelphia

From left to right..  Police Commissioner Richard Ross, Jr.; Bernie Prazenica, PAL Board Chair and General Manager of WPVI TV/6abc; Mel Brodsky, Rich Ost; Lt. Evelyn Cintron, PAL’s Commanding Officer and Ted Qualli, PAL’s Executive Director. 

FDA Confirms Increased Risk of Leg and Foot Amputations with the Diabetes Medicine Canagliflozin

Based on new data from two large clinical trials, the U.S. Food and Drug Administration (FDA) has concluded that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. We are

PrescribeWellness – Ways to Improve An Immunization Program

Click the link to see presentation done by PrescribeWellness: https://www.pscp.tv/PrescribeWell/1RDxlZVnkWRGL

Top Pharmas Team With Express Scripts To Gin Up Savings for Cash-paying Patients

http://www.fiercepharma.com/pharma/amid-pricing-scrutiny-drugmakers-team-up-express-scripts-to-find-savings-for-cash-paying?mkt_tok=eyJpIjoiWWpGak1ETmxOamxsTkRVMSIsInQiOiIzK1VGOEY4S1A0UzlzVm1rczM0cmg0cngyemNGbmtUekNRZXJYcW1maXZQbzB0bzE5T1FSQ1BoeFVIRnNHeWYxb0VLa1wvczNBcWVOWlR5ZmhIaHZNUWlCY1kxOFlubXI1SHVoOUVxNTBDcXJDbWpIYklwXC9TaDFzUUtcLzRoZWNmSiJ9&mrkid=41785545&utm_medium=nl&utm_source=internal  

Pharm Tech Bill Passes the House

The Pennsylvania House of Representatives passed House Bill 454 today; this bill would require pharmacy technicians to register with the State Board of Pharmacy. The bill now awaits consideration from the Pennsylvania State Senate. You can learn more about this

You’re Overpaying for Drugs and Your Pharmacist Can’t Tell You

https://www.bloomberg.com/news/articles/2017-02-24/sworn-to-secrecy-drugstores-stay-silent-as-customers-overpay  

NCPA Advocacy Center Update – Week Ending May 13, 2017

NCPA CEO Discusses Prescription Drugs with HHS Secretary Price:  This week NCPA CEO Doug Hoey represented the organization in a meeting with the Health and Human Services (HHS) Secretary, Dr. Tom Price. Earlier this year NCPA requested a meeting with

NCPA Members – Free Webinar for CE Credit on May 10th

NCPA Members—Free Webinar for CE credit on May 10th. Understand the major statutes and regulations impacting pharmacy compliance today. Get Tips to Be Proactively Compliant on a May 10 Webinar (& Earn CE) Over the past several years, government enforcement in

NCPA Advocacy Center Update – Week Ending May 6, 2017

Medicare Pharmacy Choice and Access Bill Introduced in the Senate: The Ensuring Seniors Access to Local Pharmacies Act, S. 1044, was introduced by Senators Shelley Moore Capito (R-WV), Sherrod Brown (D-OH), Tom Cotton (R-AK) and Joe Manchin (D-WV).  The bill

Keystone and PARD Gives Back

The employees of Keystone and PARD gave back today by volunteering their time at the Choice Foods pantry at KleinLife on Jamison Avenue in Philadelphia.  Stocking shelves and filling orders gave the team a chance to pay it forward. From

Interesting Article on Pet Meds

https://www.linkedin.com/pulse/pet-medication-market-growing-joshua-pirestani?trk=v-feed&lipi=urn%3Ali%3Apage%3Ad_flagship3_detail_base%3B4sEiRQyi%2FPzOR4v46DJsSw%3D%3D  

Prescription Drug Monitoring Program (PDMP)

General Q&A Please click here for more information on the Prescription Drug Monitoring Program.

A Secret Profit Formula Love by Drug Middlemen Is at Risk

https://www.bloomberg.com/news/articles/2017-04-26/secret-profit-formulas-at-risk-as-drug-middleman-loses-contract    

NCPA Advocacy Center Update – Week Ending April 29, 2017

NCPA Congressional Pharmacy Fly-In Wrap Up:  NCPA held its 49th annual meeting with over 200 independent community pharmacists visiting Capitol Hill in Washington, D.C. this week to share with Congress real solutions to the problem of skyrocketing prescription drugs.  The

Top